약물전달 기기 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 용도별, 투여 경로별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Route of Administration, By End User, By Region and Competition, 2020-2030F
상품코드:1878977
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 약물전달 기기 시장은 2024년에 2,613억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 7.91%로 성장하여 4,126억 6,000만 달러에 달할 것으로 예측됩니다.
약물전달 기기는 주사제, 경구제, 경피제, 흡입제 등 다양한 경로를 통해 치료제를 제어된 최적의 방법으로 체내에 투여할 수 있도록 설계된 전문 의료기술입니다. 시장 확대는 전 세계적으로 장기적인 약물 관리가 필요한 만성질환의 증가 추세와 자가 투약을 포함한 환자 중심 치료 솔루션에 대한 수요 증가로 인해 크게 촉진되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
2,613억 2,000만 달러
시장 규모 : 2030년
4,126억 6,000만 달러
CAGR : 2025-2030년
7.91%
가장 빠르게 성장하는 부문
주사제
최대 시장
북미
주요 시장 촉진요인
전 세계적으로 만성질환의 부담이 증가함에 따라 약물전달 기기에 대한 수요가 크게 증가하고 있습니다. 당뇨병, 심혈관질환, 암과 같은 질병을 효과적으로 장기적으로 관리하기 위해서는 신뢰할 수 있고 종종 전문적인 투여 방법이 필요하기 때문입니다. 동반질환 비율이 높은 고령층으로의 인구통계학적 변화는 재택의료를 포함한 다양한 의료현장에서 정확한 투약과 환자의 복약 순응도를 향상시킬 수 있는 첨단 솔루션의 필요성을 높이고 있습니다.
주요 시장 과제
지역별로 복잡하고 변화하는 규제 환경은 세계 약물전달 기기 시장의 성장에 큰 장벽으로 작용하고 있습니다. 제품 개발, 임상시험, 시판 후 조사에 대한 요구사항이 지역마다 다르기 때문에 제조업체의 예측 불가능성과 복잡성이 크게 증가하고 있습니다.
주요 시장 동향
재택 및 자가 투약 기기의 급속한 확산은 의료 제공의 혁신적 전환을 의미하며, 환자가 전통적인 임상 환경을 넘어 자율적으로 치료를 관리할 수 있도록 하고 있습니다. 이러한 진화는 특히 만성질환 관리 분야에서 편의성, 비용 효율성, 치료 순응도 향상에 대한 요구가 증가함에 따라 추진되고 있습니다.
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 약물전달 기기 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
용도별(암, 심혈관질환, 당뇨병, 감염증, 기타 용도)
투여 경로별(주사제, 외용제, 안과용, 기타)
최종사용자별(병원, 외래 수술 센터, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 약물전달 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 약물전달 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 약물전달 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 약물전달 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 약물전달 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 약물전달 기기 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Pfizer Inc.
Novartis AG
F. Hoffmann-La Roche Ltd
Johnson and Johnson
Bayer AG
Becton, Dickinson and Company
Altaris Capital Partners, LLC
Holozymes Inc.(Antares Pharma Inc.)
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Drug Delivery Devices Market , valued at USD 261.32 Billion in 2024, is projected to experience a CAGR of 7.91% to reach USD 412.66 Billion by 2030. Drug delivery devices are specialized medical technologies engineered to administer therapeutic substances to the body in a controlled and optimized manner, encompassing various routes such as injectable, oral, transdermal, and inhalation systems. The market's expansion is significantly driven by the increasing global prevalence of chronic diseases requiring long-term medication management and a growing demand for patient-centric care solutions, including self-administration.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 261.32 Billion
Market Size 2030
USD 412.66 Billion
CAGR 2025-2030
7.91%
Fastest Growing Segment
Injectable
Largest Market
North America
Key Market Drivers
The increasing global burden of chronic diseases significantly propels the demand for drug delivery devices, as effective long-term management of conditions like diabetes, cardiovascular diseases, and cancer necessitates reliable and often specialized administration methods. This demographic shift towards an older population with higher rates of comorbidities fuels the need for advanced solutions capable of precise dosing and improved patient adherence across various care settings, including home care. According to the World Health Organization's "Noncommunicable diseases" fact sheet, in 2021, 43 million people died from an NCD, accounting for 75% of non-pandemic-related deaths globally, underscoring the widespread need for effective therapeutic interventions delivered efficiently via modern devices.
Key Market Challenges
The complex and evolving regulatory landscape across different regions presents a significant impediment to the growth of the Global Drug Delivery Devices Market. Varying requirements for product development, clinical trials, and post-market surveillance introduce substantial unpredictability and complexity for manufacturers. This intricacy often leads to extended approval timelines and increased development expenditures, particularly for innovative combination products that integrate drugs and devices.
Key Market Trends
The rapid expansion of home-based and self-administration devices marks a transformative shift in healthcare delivery, enabling patients to manage treatments independently beyond conventional clinical settings. This evolution is primarily driven by growing demand for convenience, cost efficiency, and improved treatment adherence, particularly in chronic disease management. These solutions include user-friendly technologies such as pre-filled syringes, auto-injectors, and patch pumps, which simplify drug administration and improve the overall patient experience. Reflecting this structural change, MedTech Europe projects that the home-care segment will grow at a compound annual growth rate of 12.4% within the European medical devices market from 2025 to 2033, highlighting the accelerating transition toward decentralised care models. This momentum is further reinforced by strategic investments from leading manufacturers; for instance, Medtronic expanded 11 production lines for insulin pumps in Ireland in 2023, demonstrating its commitment to scaling capacity in response to rising demand for self-administered diabetes management solutions.
Key Market Players
Pfizer Inc.
Novartis AG
F. Hoffmann-La Roche Ltd
Johnson and Johnson
Bayer AG
Becton, Dickinson and Company
Altaris Capital Partners, LLC
Holozymes Inc. (Antares Pharma Inc.)
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd
Report Scope:
In this report, the Global Drug Delivery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Drug Delivery Devices Market , By Application:
Cancer
Cardiovascular
Diabetes
Infectious Diseases
Other Applications
Drug Delivery Devices Market , By Route of Administration:
Injectable
Topical
Ocular
Others
Drug Delivery Devices Market , By End User:
Hospitals
Ambulatory Surgical Centers
Others
Drug Delivery Devices Market , By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Drug Delivery Devices Market .
Available Customizations:
Global Drug Delivery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Drug Delivery Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Application (Cancer, Cardiovascular, Diabetes, Infectious Diseases, Other Applications)
5.2.2. By Route of Administration (Injectable, Topical, Ocular, Others)
5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Drug Delivery Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application
6.2.2. By Route of Administration
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Drug Delivery Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Application
6.3.1.2.2. By Route of Administration
6.3.1.2.3. By End User
6.3.2. Canada Drug Delivery Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Application
6.3.2.2.2. By Route of Administration
6.3.2.2.3. By End User
6.3.3. Mexico Drug Delivery Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Application
6.3.3.2.2. By Route of Administration
6.3.3.2.3. By End User
7. Europe Drug Delivery Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Route of Administration
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Drug Delivery Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By End User
7.3.2. France Drug Delivery Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By End User
7.3.3. United Kingdom Drug Delivery Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By End User
7.3.4. Italy Drug Delivery Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Application
7.3.4.2.2. By Route of Administration
7.3.4.2.3. By End User
7.3.5. Spain Drug Delivery Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Application
7.3.5.2.2. By Route of Administration
7.3.5.2.3. By End User
8. Asia Pacific Drug Delivery Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By Route of Administration
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Drug Delivery Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By End User
8.3.2. India Drug Delivery Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By End User
8.3.3. Japan Drug Delivery Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By End User
8.3.4. South Korea Drug Delivery Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By End User
8.3.5. Australia Drug Delivery Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By End User
9. Middle East & Africa Drug Delivery Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By Route of Administration
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Drug Delivery Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By End User
9.3.2. UAE Drug Delivery Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By End User
9.3.3. South Africa Drug Delivery Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By End User
10. South America Drug Delivery Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Route of Administration
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Drug Delivery Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By End User
10.3.2. Colombia Drug Delivery Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By End User
10.3.3. Argentina Drug Delivery Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Drug Delivery Devices Market : SWOT Analysis
